Incannex Healthcare Ltd Stock Price To Sales
| IXHL Stock | USD 1.78 0.04 2.20% |
Incannex Healthcare Ltd fundamentals help investors to digest information that contributes to Incannex Healthcare's financial success or failures. It also enables traders to predict the movement of Incannex Stock. The fundamental analysis module provides a way to measure Incannex Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Incannex Healthcare stock.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 4.6 K | 4.3 K |
Incannex | Price To Sales |
Incannex Healthcare Ltd Company Price To Sales Analysis
Incannex Healthcare's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Incannex Healthcare Price To Sales | 2,706 X |
Most of Incannex Healthcare's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Incannex Healthcare Ltd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Incannex Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for Incannex Healthcare is extremely important. It helps to project a fair market value of Incannex Stock properly, considering its historical fundamentals such as Price To Sales. Since Incannex Healthcare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Incannex Healthcare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Incannex Healthcare's interrelated accounts and indicators.
Click cells to compare fundamentals
Incannex Price To Sales Historical Pattern
Today, most investors in Incannex Healthcare Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Incannex Healthcare's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Incannex Healthcare price to sales as a starting point in their analysis.
Incannex Healthcare Price To Sales |
| Timeline |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Incannex Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, Incannex Healthcare Ltd has a Price To Sales of 2.71 K times. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is notably lower than that of the firm.
Incannex Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Incannex Healthcare's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Incannex Healthcare could also be used in its relative valuation, which is a method of valuing Incannex Healthcare by comparing valuation metrics of similar companies.Incannex Healthcare is currently under evaluation in price to sales category among its peers.
Incannex Healthcare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Incannex Healthcare from analyzing Incannex Healthcare's financial statements. These drivers represent accounts that assess Incannex Healthcare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Incannex Healthcare's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 2.5B | 3.6B | 1.1B | 28.3M | 47.7M | 45.3M | |
| Enterprise Value | 2.5B | 3.6B | 1.1B | 6.7M | 42.2M | 40.1M |
Incannex Fundamentals
| Return On Equity | -1.15 | ||||
| Return On Asset | -0.57 | ||||
| Operating Margin | (538.33) % | ||||
| Current Valuation | 28.19 M | ||||
| Shares Outstanding | 17.64 M | ||||
| Shares Owned By Insiders | 25.86 % | ||||
| Shares Owned By Institutions | 4.13 % | ||||
| Number Of Shares Shorted | 27.53 K | ||||
| Price To Book | 4.76 X | ||||
| Price To Sales | 2,706 X | ||||
| Revenue | 12 K | ||||
| Gross Profit | 1.01 M | ||||
| EBITDA | (18.5 M) | ||||
| Net Income | (18.46 M) | ||||
| Cash And Equivalents | 37.5 M | ||||
| Cash Per Share | 0.68 X | ||||
| Total Debt | 373 K | ||||
| Current Ratio | 18.84 X | ||||
| Book Value Per Share | 0.64 X | ||||
| Cash Flow From Operations | (15.85 M) | ||||
| Short Ratio | 1.76 X | ||||
| Earnings Per Share | (1.36) X | ||||
| Beta | 2.21 | ||||
| Market Capitalization | 32.47 M | ||||
| Total Asset | 17.05 M | ||||
| Retained Earnings | (110.67 M) | ||||
| Working Capital | 10.58 M | ||||
| Net Asset | 17.05 M |
About Incannex Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Incannex Healthcare Ltd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Incannex Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Incannex Healthcare Ltd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Incannex Healthcare Piotroski F Score and Incannex Healthcare Altman Z Score analysis. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incannex Healthcare. If investors know Incannex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incannex Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.36) | Revenue Per Share 0.001 | Quarterly Revenue Growth 0.296 | Return On Assets (0.57) | Return On Equity (1.15) |
The market value of Incannex Healthcare is measured differently than its book value, which is the value of Incannex that is recorded on the company's balance sheet. Investors also form their own opinion of Incannex Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Incannex Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incannex Healthcare's market value can be influenced by many factors that don't directly affect Incannex Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incannex Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incannex Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incannex Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.